Buprenorphine Medication Assisted Treatment Monitoring 2, Urine

CPT: 80307
Print Share

Test Details

Synonyms

  • MAT Drug Screen

Use

Detect and confirm presence of prescribed and illicit drugs for monitoring Suboxone™/buprenorphine medication assisted treatment (MAT). Please note: This testing is designed specifically for monitoring patients who are on Suboxone™/buprenorphine only. This testing should not be used for monitoring chronic pain patients (medical drug monitoring) or methadone medication assisted treatment.

Limitations

Some components of this panel were developed, and performance characteristics determined, by LabCorp (EtG, Carisoprodol, Fentanyl, Tapentadol, and Gabapentin). They have not been cleared or approved by the US Food and Drug Administration (FDA).

Methodology

Initial presumptive testing by immunoassay at the following testing thresholds: buprenorphine, 5 ng/mL; alcohol biomarkers (EtG, EtS), 500 ng/mL; amphetamines, 500 ng/mL; barbiturates, 200 ng/mL; benzodiazepines, 200 ng/mL; cocaine metabolite, 150 ng/mL; phencyclidine, 25 ng/mL; cannabinoids (THC), 20 ng/mL; heroin metabolite (6-AM), 10 ng/mL; opiates, 300 ng/mL; oxycodones, 100 ng/mL; tapentadol, 200 ng/mL; fentanyl, 2.0 ng/mL; methadone, 300 ng/mL; propoxyphene, 300 ng/mL; tramadol, 200 ng/mL; carisoprodol, 100 ng/mL; gabapentin, 1.5 μg/ml. Presumptive positives are confirmed by definitive mass spectrometry (LC/MS-MS or GC/MS).

Additional Information

Testing referred to MEDTOX Laboratories, Inc.

Specimen Requirements

Specimen

Urine

Volume

30 mL

Minimum Volume

15 mL

Collection

Random Urine

Storage Instructions

Ambient

Stability Requirements

Room Temperature: 5 days

Causes for Rejection

Insufficient volume; no ID on container; urine from preservative tube

For Providers

Please login to order a test.

 

© 2018  Laboratory Corporation of America® Holdings and Lexi-Comp Inc. All Rights Reserved.

CPT Statement/Profile Statement

The LOINC® codes are copyright © 1994-2018, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. Permission is granted in perpetuity, without payment of license fees or royalties, to use, copy, or distribute the LOINC® codes for any commercial or non-commercial purpose, subject to the terms under the license agreement found at https://loinc.org/license/. Additional information regarding LOINC® codes can be found at LOINC.org, including the LOINC Manual, which can be downloaded at LOINC.org/downloads/files/LOINCManual.pdf